| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8233196 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 8 Pages |
Abstract
Hyperfractionated concomitant boost proton radiotherapy (96.6 GyE in 56 fractions) for GBM was tolerable and beneficial if the target size was well considered. Further studies are warranted to pursue the possibility of controlling border region recurrences.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Masashi M.D., Ph.D., Koji M.D., Ph.D., Hiroshi M.D., Ph.D., Tetsuya M.D., Ph.D., Shingo M.D., Ph.D., Yoshiko M.D., Ph.D., Yasutaka M.D., Haruko M.D., Ayae M.D., Hidetsugu M.D., Ph.D., Shinji M.D., Ph.D., Hideyuki M.D., Ph.D., Akira M.D., Ph.D.,